Associate Professor, Medicine, Case Western Reserve University School of Medicine
Radiation Oncology
Dr. Samuel T. Chao, MD
|
|
Give Review
Samuel T. Chao works in the field of Radiation Oncology. He studied medicine at Case Western Reserve University School of Medicine. He over the years received 1 awards: "CMS Meaningful Use Stage 1 Certification". Samuel Chao is a published doctor. He published 66 publications, including: 'Quantitative Evaluation of Local Control and Wound Healing Following Surgery and Stereotactic Spine Radiosurgery (SRS) for Spine Tumors.' He accepts Medicare.
Publications
- Radiosurgery for Pediatric Brain Tumors.
- Quantitative Evaluation of Local Control and Wound Healing Following Surgery and Stereotactic Spine Radiosurgery (SRS) for Spine Tumors.
- Pathology concordance levels for meningioma classification and grading in NRG Oncology RTOG Trial 0539.
- Review of cranial radiotherapy-induced vasculopathy.
- Treatment of Large Brain Metastases With Stereotactic Radiosurgery.
- Gamma Knife radiosurgery for sellar and parasellar meningiomas: a multicenter study.
- Workflow Enhancement (WE) Improves Safety in Radiation Oncology: Putting the WE and Team Together.
- Using Higher Isodose Lines for Gamma Knife Treatment of 1 to 3 Brain Metastases is Safe and Effective.
- Results of a questionnaire regarding practice patterns for the diagnosis and treatment of intracranial radiation necrosis after SRS.
- Recurrent or refractory primary central nervous lymphoma: therapeutic considerations.
- Primary central nervous system lymphoma in the elderly: the cleveland clinic experience.
- WITHDRAWN: Challenges With the Diagnosis and Treatment of Cerebral Radiation Necrosis.
- Primary Ewing's sarcoma of the ethmoid sinus with intracranial and orbital extension: case report and literature review.
- In Reply to Reiner et al.
- The effect of tumor subtype on the time from primary diagnosis to development of brain metastases and survival in patients with breast Cancer.
- Treatment of Five or More Brain Metastases with Stereotactic Radiosurgery.
- The Importance of the Conformality, Heterogeneity, and Gradient Indices in Evaluating Gamma Knife Radiosurgery Treatment Plans for Intracranial Meningiomas.
- Summary Report on the Graded Prognostic Assessment: An Accurate and Facile Diagnosis-Specific Tool to Estimate Survival for Patients With Brain Metastases.
- Reply to drs. Mulvenna and holt.
- Marginal Recurrence Requiring Salvage Radiotherapy after Stereotactic Body Radiotherapy for Spinal Metastases.
- Radiotherapy for prolactin-secreting Pituitary tumors.
- Impact of preexisting tumor necrosis on the efficacy of stereotactic radiosurgery in the treatment of brain metastases in women with breast Cancer.
- Stereotactic radiosurgical treatment of brain metastases to the choroid plexus.
- Treatment outcomes for patients with glioblastoma multiforme and a low Karnofsky Performance Scale score on presentation to a tertiary care institution. Clinical article.
- Effect of Tumor Subtype on Survival and the Graded Prognostic Assessment for Patients With Breast Cancer and Brain Metastases.
- Recursive Partitioning Analysis Index is Predictive for Overall Survival in Patients Undergoing Spine Stereotactic Body Radiation Therapy for Spinal Metastases.
- Aggressive treatment is appropriate for glioblastoma multiforme patients 70 years old or older: a retrospective review of 206 cases.
- The role of adjuvant radiation therapy in the treatment of spinal myxopapillary ependymomas.
- Stereotactic radiosurgery for single brainstem metastases: the cleveland clinic experience.
- Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4,259 pati...
- Principal risk of peritumoral edema after stereotactic radiosurgery for intracranial meningioma is tumor-brain contact interface area.
- Chromosome 1p and 19q deletions in glioblastoma multiforme.
- Gender, race, and survival: a study in non-small-cell lung Cancer brain metastases patients utilizing the radiation therapy oncology group recursive partitioning analy...
- Long-term experience with World Health Organization grade III (malignant) meningiomas at a single institution.
- Salvage stereotactic radiosurgery effectively treats recurrences from whole-brain radiation therapy.
- Stereotactic radiosurgical treatment of brain metastases in older patients.
- Multidisciplinary management of colorectal brain metastases: a retrospective study.
- Stereotactic radiosurgical treatment of parenchymal brain metastases from prostate adenocarcinoma.
- Treatment of heterotopic ossification.
- Five-year survivors of brain metastases: a single-institution report of 32 patients.
- External beam radiation helps prevent heterotopic bone formation in patients with a history of heterotopic ossification.
- Brain metastasis and treatment.
- Stereotactic body radiotherapy is an effective treatment in reirradiating spinal metastases: current status and practical considerations for safe practice.
- Blood gene expression signatures associate with heart failure outcomes.
- Novel blood-based, five-gene biomarker set for the detection of colorectal Cancer.
- reirradiation HUMAN Spinal Cord Tolerance for Stereotactic Body Radiotherapy.
- Stereotactic radiosurgery for spinal metastases: update on treatment strategies.
- Evidence-based adjuvant therapy for gliomas: current concepts and newer developments.
- Prospective study of the short-term adverse effects of gamma knife radiosurgery.
- Principles of radiobiology of stereotactic radiosurgery and clinical applications in the central nervous system.
- Phase II trial of ritonavir/lopinavir in patients with progressive or recurrent high-grade gliomas.
- Discovery and development of 5-[(5S,9R)-9-(4-cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]non-7-yl-methyl]-3-thiophenecarboxylic acid (...
- Thio- and oxoflavopiridols, cyclin-dependent kinase 1-selective inhibitors: synthesis and biological effects.
- The sensitivity and specificity of FDG PET in distinguishing recurrent brain tumor from radionecrosis in patients treated with stereotactic radiosurgery.
- Discovery and preclinical studies of (R)-1-(4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-5- methylpyrrolo[2,1-f][1,2,4]triazin-6-yloxy)propan- 2-ol (BMS-540215), an in vivo ...
- Spine instrumentation failure after spine tumor resection and radiation: comparing conventional radiotherapy with stereotactic radiosurgery outcomes.
- Application of recursive partitioning analysis and evaluation of the use of whole brain radiation among patients treated with stereotactic radiosurgery for newly diagn...
- Acridone-based inhibitors of inosine 5'-monophosphate dehydrogenase: discovery and SAR leading to the identification of N-(2-(6-(4-ethylpiperazin-1-yl)pyridin-3-yl)pro...
- Management of recurrent brain metastasis after radiosurgery.
- When should radiotherapy for low-grade glioma be given--immediately after surgery or at the time of progression?
- Review of the treatment of trigeminal neuralgia with gamma knife radiosurgery.
- Discovery of a tetrazole-based growth hormone secretagogue: 4-(hydroxybutyl)carbamic acid 2-{5-[1-(2-amino-2-methylpropionylamino)-2- benzyloxyethyl]tetrazol-1-yl}ethy...
- Design and synthesis of a G-protein-coupled receptor antagonist library of aryloxyalkanolamines using a polymer-supported acyclic acetal linker.
- Stereotactic radiosurgery as single-modality treatment of incidentally identified renal cell carcinoma brain metastases.
- Gamma knife stereotactic radiosurgery for the management of incidentally-identified brain metastasis from non-small cell lung Cancer.
Schools
Case Western Reserve University School of Medicine
Cleveland Clinic
Procedures Preformed
- Stereotactic Radiosurgery, Spinal
Conditions Treated
- Pituitary Gland Cancer
Doctors Specialties
- Neuropathology
- Radiation Oncology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
Cleveland Clinic Foundation -
Case Western Reserve University School of Medicine
Hospital
-
University Hospitals Parma Medical Center -
Cleveland Clinic
Drug Facts
| NPI NUMBER | 1386658656 | |
| NPPES Provider LastName | CHAO | |
| NPPES Provider FirstName | SAMUEL | |
| NPPES Provider ZIPCode | 441950001 | |
| NPPES Provider State | OH | |
| Specialty Description | Radiation Oncology | |
| Total Claim Count | 66.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1386658656 |
| Last Name Of The Provider | CHAO |
| First Name Of The Provider | SAMUEL |
| View All |
Similar Doctors
|
|
Dr. Andrew D. Vassil, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mark L. Cohen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Dan X. Cai, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Pierluigi Gambetti, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Susan M. Staugaitis, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jennifer A. Dorth, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Prachi Jain, MD |
|
|
Dr. Carl R. Peterson III, MD |
|
Min Yao, MB
This Doctor is OpenDoctor Recommended.
|